PreDxion Bio
YC S17 · Inactive · Rapid, scalable diagnostic for SARS-CoV-2 and beyond
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 AminoAnalyticaShared: nanosensors, diagnostic, daysActiveAI | AI | Active | YCS24 |
 Correlia BiosystemsShared: microfluidics, rapid, diagnosticInactiveOther | Other | Inactive | YCW18 |
 ScoutShared: covid-19, diagnostic, testActiveOther | Other | Active | YCW22 |
 Astek DiagnosticsShared: microfluidics, diagnostic, patientActiveOther | Other | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 MoichorShared: diagnosticActiveAI | AI | Active | YCW21 |
 Biobot AnalyticsShared: public health, health official, biomarkerActiveData | Data | Active | YCW18 |
 Synapsica HealthcareShared: diagnosticInactiveAI | AI | Inactive | YCW20 |
 ScanbaseShared: rapid, diagnostic, testActiveAI | AI | Active | YCW23 |
 LSK TechnologiesShared: diagnosticAcquiredOther | Other | Acquired | YCS20 |
Also from S17
All of S17
About PreDxion Bio
PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.
- YC batch
- S17 · Summer 2017
- Status, per YC
- Inactive
- Category
- Other
- Team size
- 6
- Location
- San Francisco, CA, USA; South San Francisco, CA, USA
- Checked
- 35m ago
YC tags: Microfluidics, Nanosensors, COVID-19
PreDxion Bio: questions
Which YC batch was PreDxion Bio in?
PreDxion Bio was in Y Combinator's Summer 2017 batch (S17).
Is PreDxion Bio still active?
Y Combinator lists PreDxion Bio as inactive.
Where is PreDxion Bio based?
PreDxion Bio lists San Francisco, CA, USA; South San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.